← All organizations

Pliant Therapeutics

For profitWebsite ↗

Also known as: Pliant Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 16, 2023

Timeline

2010s

Jun 1, 2015
Pliant Therapeutics— Founded

Drugs by trial phase (4 distinct, 8 trials)

Phase 2 (1 own, 0 via acquisition)

Bexotegrast

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (14)

NCT06097260Study directorPhase 2Nov 16, 2023
NCT06097260Lead sponsorPhase 2Nov 16, 2023
NCT06270706OfficialPhase 1Aug 30, 2023
NCT06270706Lead sponsorPhase 1Aug 30, 2023
NCT05621252Lead sponsorPhase 2Jul 13, 2022
NCT04565249Study directorPhase 2Oct 22, 2020
NCT04565249Lead sponsorPhase 2Oct 22, 2020
NCT04480840Study directorPhase 2Jul 27, 2020
NCT04480840Lead sponsorPhase 2Jul 27, 2020
NCT04396756Lead sponsorPhase 2Mar 3, 2020
NCT04396756Study directorPhase 2Mar 3, 2020
NCT04072315Lead sponsorPhase 2Sep 9, 2019
NCT04072315Study directorPhase 2Sep 9, 2019
NCT03183570CollaboratorEarly Phase 1Jun 25, 2017

Details

Founded: Redwood City, CA, US Jun 1, 2015
Last known activity: Nov 16, 2023